LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Your last searches

  1. AU="Mendelow, Alexander David"
  2. AU="Pereira, Taci"
  3. AU="Natalie Taylor"
  4. AU="Moradi, Tayebeh"
  5. AU="Ramesh C. Santra"
  6. AU="Selvarajah, Aravinda"
  7. AU="Vaisman, Adva"
  8. AU="Rádiková, Žofia"
  9. AU=Poulin Stphane P.

Search results

Result 1 - 8 of total 8

Search options

  1. Article ; Online: Acute care bundles should be used for patients with intracerebral haemorrhage: An expert consensus statement.

    Parry-Jones, Adrian R / Järhult, Susann J / Kreitzer, Natalie / Morotti, Andrea / Toni, Danilo / Seiffge, David / Mendelow, Alexander David / Patel, Hiren / Brouwers, Hens Bart / Klijn, Catharina Jm / Steiner, Thorsten / Gibler, Walter Brian / Goldstein, Joshua N

    European stroke journal

    2023  Volume 9, Issue 2, Page(s) 295–302

    Abstract: Purpose: Intracerebral haemorrhage (ICH) is the most devastating form of stroke and a major cause of disability. Clinical trials of individual therapies have failed to definitively establish a specific beneficial treatment. However, clinical trials of ... ...

    Abstract Purpose: Intracerebral haemorrhage (ICH) is the most devastating form of stroke and a major cause of disability. Clinical trials of individual therapies have failed to definitively establish a specific beneficial treatment. However, clinical trials of introducing care bundles, with multiple therapies provided in parallel, appear to clearly reduce morbidity and mortality. Currently, not enough patients receive these interventions in the acute phase.
    Methods: We convened an expert group to discuss best practices in ICH and to develop recommendations for bundled care that can be delivered in all settings that treat acute ICH, with a focus on European healthcare systems.
    Findings: In this consensus paper, we argue for widespread implementation of formalised care bundles in ICH, including specific metrics for time to treatment and criteria for the consideration of neurosurgical therapy.
    Discussion: There is an extraordinary opportunity to improve clinical care and clinical outcomes in this devastating disease. Substantial evidence already exists for a range of therapies that can and should be implemented now.
    MeSH term(s) Humans ; Cerebral Hemorrhage/therapy ; Patient Care Bundles/standards ; Consensus
    Language English
    Publishing date 2023-12-27
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2851287-X
    ISSN 2396-9881 ; 2396-9873
    ISSN (online) 2396-9881
    ISSN 2396-9873
    DOI 10.1177/23969873231220235
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Swiss trial of decompressive craniectomy versus best medical treatment of spontaneous supratentorial intracerebral haemorrhage (SWITCH): an international, multicentre, randomised-controlled, two-arm, assessor-blinded trial.

    Fischer, Urs / Fung, Christian / Beyeler, Seraina / Bütikofer, Lukas / Z'Graggen, Werner / Ringel, Florian / Gralla, Jan / Schaller, Karl / Plesnila, Nikolaus / Strbian, Daniel / Arnold, Marcel / Hacke, Werner / Jüni, Peter / Mendelow, Alexander David / Stapf, Christian / Al-Shahi Salman, Rustam / Bressan, Jenny / Lerch, Stefanie / Bassetti, Claudio L A /
    Mattle, Heinrich P / Raabe, Andreas / Beck, Jürgen

    European stroke journal

    2024  , Page(s) 23969873241231047

    Abstract: Rationale: Decompressive craniectomy (DC) is beneficial in people with malignant middle cerebral artery infarction. Whether DC improves outcome in spontaneous intracerebral haemorrhage (ICH) is unknown.: Aim: To determine whether DC without haematoma ...

    Abstract Rationale: Decompressive craniectomy (DC) is beneficial in people with malignant middle cerebral artery infarction. Whether DC improves outcome in spontaneous intracerebral haemorrhage (ICH) is unknown.
    Aim: To determine whether DC without haematoma evacuation plus best medical treatment (BMT) in people with ICH decreases the risk of death or dependence at 6 months compared to BMT alone.
    Methods and design: SWITCH is an international, multicentre, randomised (1:1), two-arm, open-label, assessor-blinded trial. Key inclusion criteria are age ⩽75 years, stroke due to basal ganglia or thalamic ICH that may extend into cerebral lobes, ventricles or subarachnoid space, Glasgow coma scale of 8-13, NIHSS score of 10-30 and ICH volume of 30-100 mL. Randomisation must be performed <66 h after onset and DC <6 h after randomisation. Both groups will receive BMT. Participants randomised to the treatment group will receive DC of at least 12 cm in diameter according to institutional standards.
    Sample size: A sample of 300 participants randomised 1:1 to DC plus BMT versus BMT alone provides over 85% power at a two-sided alpha-level of 0.05 to detect a relative risk reduction of 33% using a chi-squared test.
    Outcomes: The primary outcome is the composite of death or dependence, defined as modified Rankin scale score 5-6 at 6 months. Secondary outcomes include death, functional status, quality of life and complications at 180 days and 12 months.
    Discussion: SWITCH will inform physicians about the outcomes of DC plus BMT in people with spontaneous deep ICH, compared to BMT alone.
    Trial registration: ClinicalTrials.gov Identifier: NCT02258919.
    Language English
    Publishing date 2024-02-12
    Publishing country England
    Document type Journal Article
    ZDB-ID 2851287-X
    ISSN 2396-9881 ; 2396-9873
    ISSN (online) 2396-9881
    ISSN 2396-9873
    DOI 10.1177/23969873241231047
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Retrospective Methods Analysis of Semiautomated Intracerebral Hemorrhage Volume Quantification From a Selection of the STICH II Cohort (Early Surgery Versus Initial Conservative Treatment in Patients With Spontaneous Supratentorial Lobar Intracerebral Haematomas).

    Haley, Mark D / Gregson, Barbara A / Mould, W Andrew / Hanley, Daniel F / Mendelow, Alexander David

    Stroke

    2018  Volume 49, Issue 2, Page(s) 325–332

    Abstract: Background and purpose: The ABC/2 method for calculating intracerebral hemorrhage (ICH) volume has been well validated. However, the formula, derived from the volume of an ellipse, assumes the shape of ICH is elliptical. We sought to compare the ... ...

    Abstract Background and purpose: The ABC/2 method for calculating intracerebral hemorrhage (ICH) volume has been well validated. However, the formula, derived from the volume of an ellipse, assumes the shape of ICH is elliptical. We sought to compare the agreement of the ABC/2 formula with other methods through retrospective analysis of a selection of the STICH II cohort (Early Surgery Versus Initial Conservative Treatment in Patients With Spontaneous Supratentorial Lobar Intracerebral Haematomas).
    Methods: From 390 patients, 739 scans were selected from the STICH II image archive based on the availability of a CT scan compatible with OsiriX DICOM viewer. ICH volumes were calculated by the reference standard semiautomatic segmentation in OsiriX software and compared with calculated arithmetic methods (ABC/2, ABC/2.4, ABC/3, and 2/3SC) volumes. Volumes were compared by difference plots for specific groups: randomization ICH (n=374), 3- to 7-day postsurgical ICH (n=206), antithrombotic-associated ICH (n=79), irregular-shape ICH (n=703) and irregular-density ICH (n=650). Density and shape were measured by the Barras ordinal shape and density groups (1-5).
    Results: The ABC/2.4 method had the closest agreement to the semiautomatic segmentation volume in all groups, except for the 3- to 7-day postsurgical ICH group where the ABC/3 method was superior.
    Conclusions: Although the ABC/2 formula for calculating elliptical ICH is well validated, it must be used with caution in ICH scans where the elliptical shape of ICH is a false assumption. We validated the adjustment of the ABC/2.4 method in randomization, antithrombotic-associated, heterogeneous-density, and irregular-shape ICH.
    Clinical trial registration: URL: http://www.isrctn.com/ISRCTN22153967. Unique identifier: ISRCTN22153967.
    MeSH term(s) Aged ; Aged, 80 and over ; Cerebral Hemorrhage/etiology ; Cerebral Hemorrhage/surgery ; Cohort Studies ; Conservative Treatment/methods ; Early Medical Intervention ; Female ; Hematoma/complications ; Humans ; Image Processing, Computer-Assisted ; Male ; Middle Aged ; Retrospective Studies ; Time Factors ; Tomography, X-Ray Computed/methods ; Treatment Outcome
    Language English
    Publishing date 2018
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 80381-9
    ISSN 1524-4628 ; 0039-2499 ; 0749-7954
    ISSN (online) 1524-4628
    ISSN 0039-2499 ; 0749-7954
    DOI 10.1161/STROKEAHA.117.016677
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Carotid endarterectomy—safe and effective in a neurosurgeon's hands: a 25-year single-surgeon experience.

    Mukerji, Nitin / Manjunath Prasad, Kuskoor Seetharam / Vivar, Ramon / Mendelow, Alexander David

    World neurosurgery

    2015  Volume 83, Issue 1, Page(s) 74–79

    Abstract: Objective: Carotid endarterectomy (CEA) is a procedure performed by both vascular surgeons and neurosurgeons in the UK. We present a single neurosurgeon's experience of 728 CEAs over 25 years, performed under both general and local anesthesia, and ... ...

    Abstract Objective: Carotid endarterectomy (CEA) is a procedure performed by both vascular surgeons and neurosurgeons in the UK. We present a single neurosurgeon's experience of 728 CEAs over 25 years, performed under both general and local anesthesia, and discuss the results in this context. Our objective was to report on the efficacy of CEA in the hands of a neurosurgeon.
    Methods: Prospective outcome data were collected for all patients who underwent CEA performed by the senior author (A.D.M.) from 1987 to 2011. Data evaluated included patient age, sex, surgical indication, preoperative characteristics, diagnostic modalities used, shunt usage, operative time, any neurological deterioration during or after surgery, and early postoperative problems. Outcome measures used were 30-day death and 30-day disabling stroke. The results were tabulated and analyzed using JMP 8.0.2 (SAS Inc., Cary, NC).
    Results: The 30-day death rate was 0.8% and the 30-day disabling stroke rate was 1.7% in our series. The mean operative time was 135 minutes (±38.1), and the mean clamp time was 28.4 minutes (±8.5). In the subset of patients who had the operation performed under local anesthesia (n = 616), the disabling stroke rate was 1.6% and the death rate was 0.6%. In the subset of asymptomatic patients (n = 194), the 30-day death and 30-day disabling stroke rates were each 1%. Postoperative complications were uncommon.
    Conclusions: According to our data, CEA under local anesthesia is safe procedure in the hands of a neurosurgeon and would be recommended according to the clinical presentation and local guidelines.
    MeSH term(s) Aged ; Anesthesia, General/economics ; Anesthesia, Local/economics ; Cost-Benefit Analysis ; Endarterectomy, Carotid/adverse effects ; Endarterectomy, Carotid/methods ; Endarterectomy, Carotid/mortality ; Female ; Humans ; Intraoperative Complications/epidemiology ; Male ; Middle Aged ; Neurosurgery/economics ; Neurosurgery/statistics & numerical data ; Neurosurgical Procedures/adverse effects ; Neurosurgical Procedures/methods ; Neurosurgical Procedures/mortality ; Postoperative Complications/epidemiology ; Prospective Studies ; Retrospective Studies ; Stroke/epidemiology ; Stroke/prevention & control ; Surgeons ; Treatment Outcome
    Language English
    Publishing date 2015-01
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2534351-8
    ISSN 1878-8769 ; 1878-8750
    ISSN (online) 1878-8769
    ISSN 1878-8750
    DOI 10.1016/j.wneu.2013.02.088
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Characteristics of traumatic intracerebral haemorrhage: An assessment of screening logs from the STITCH(Trauma) Trial.

    Francis, Richard / Gregson, Barbara A / Mendelow, Alexander David / Rowan, Elise

    British journal of neurosurgery

    2015  Volume 29, Issue 5, Page(s) 655–660

    Abstract: Introduction: In undertaking international neurosurgical trials it is useful to understand international patient demographics and potential patient populations that study results will apply to. The STITCH(Trauma) trial included 59 centres from 20 ... ...

    Abstract Introduction: In undertaking international neurosurgical trials it is useful to understand international patient demographics and potential patient populations that study results will apply to. The STITCH(Trauma) trial included 59 centres from 20 countries, which were requested to screen all patients with traumatic intracerebral haemorrhage. This paper reviews these data.
    Materials and methods: Demographic, clinical and exclusion reason data were analysed. Comparisons were made between patients who were included in the trial and patients who were potentially eligible (but not included in the trial) and patients who were not potentially eligible.
    Results: Screening evidence was returned for 1735 patients, 11% of these may potentially have been eligible, of whom 52% were not included because consent could not be gained. By country, median age per centre ranged from 26 years (Egypt) to 67 years (Germany), median time from injury to screening ranged from 5 h (Germany and Nepal) to 16 h (India), median intracerebral haemorrhage (ICH) volume ranged from 5 ml (Germany) to 30 ml (China), the proportion of male patients ranged from 56% (Egypt) to 91% (Canada) and the proportion of patients with both pupils reactive ranged from 68% (China) to 98% (Nepal). The most common exclusion reasons were ICH volume < 10 ml (49%) and presence of subdural haemorrhage/extradural haemorrhage or SDH/EDH requiring surgery (20%).
    Conclusion: Data presented here including international patient demographics and reasons for patient ineligibility will be useful for future traumatic ICH studies.
    MeSH term(s) Adult ; Age Factors ; Aged ; Cerebral Hemorrhage, Traumatic/diagnosis ; Cerebral Hemorrhage, Traumatic/epidemiology ; Cerebral Hemorrhage, Traumatic/therapy ; Clinical Trials as Topic ; Female ; Humans ; Male ; Middle Aged ; Neurosurgery/statistics & numerical data ; Neurosurgical Procedures/statistics & numerical data ; Patient Selection ; Reflex, Pupillary ; Research Design ; Sex Factors ; Socioeconomic Factors
    Language English
    Publishing date 2015
    Publishing country England
    Document type Journal Article ; Multicenter Study ; Research Support, Non-U.S. Gov't
    ZDB-ID 639029-8
    ISSN 1360-046X ; 0268-8697
    ISSN (online) 1360-046X
    ISSN 0268-8697
    DOI 10.3109/02688697.2015.1054349
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Decompressive craniectomy plus best medical treatment versus best medical treatment alone for spontaneous severe deep supratentorial intracerebral haemorrhage: a randomised controlled clinical trial.

    Beck, Jürgen / Fung, Christian / Strbian, Daniel / Bütikofer, Lukas / Z'Graggen, Werner J / Lang, Matthias F / Beyeler, Seraina / Gralla, Jan / Ringel, Florian / Schaller, Karl / Plesnila, Nikolaus / Arnold, Marcel / Hacke, Werner / Jüni, Peter / Mendelow, Alexander David / Stapf, Christian / Al-Shahi Salman, Rustam / Bressan, Jenny / Lerch, Stefanie /
    Hakim, Arsany / Martinez-Majander, Nicolas / Piippo-Karjalainen, Anna / Vajkoczy, Peter / Wolf, Stefan / Schubert, Gerrit A / Höllig, Anke / Veldeman, Michael / Roelz, Roland / Gruber, Andreas / Rauch, Philip / Mielke, Dorothee / Rohde, Veit / Kerz, Thomas / Uhl, Eberhard / Thanasi, Enea / Huttner, Hagen B / Kallmünzer, Bernd / Jaap Kappelle, L / Deinsberger, Wolfgang / Roth, Christian / Lemmens, Robin / Leppert, Jan / Sanmillan, Jose L / Coutinho, Jonathan M / Hackenberg, Katharina A M / Reimann, Gernot / Mazighi, Mikael / Bassetti, Claudio L A / Mattle, Heinrich P / Raabe, Andreas / Fischer, Urs

    Lancet (London, England)

    2024  

    Abstract: Background: It is unknown whether decompressive craniectomy improves clinical outcome for people with spontaneous severe deep intracerebral haemorrhage. The SWITCH trial aimed to assess whether decompressive craniectomy plus best medical treatment in ... ...

    Abstract Background: It is unknown whether decompressive craniectomy improves clinical outcome for people with spontaneous severe deep intracerebral haemorrhage. The SWITCH trial aimed to assess whether decompressive craniectomy plus best medical treatment in these patients improves outcome at 6 months compared to best medical treatment alone.
    Methods: In this multicentre, randomised, open-label, assessor-blinded trial conducted in 42 stroke centres in Austria, Belgium, Finland, France, Germany, the Netherlands, Spain, Sweden, and Switzerland, adults (18-75 years) with a severe intracerebral haemorrhage involving the basal ganglia or thalamus were randomly assigned to receive either decompressive craniectomy plus best medical treatment or best medical treatment alone. The primary outcome was a score of 5-6 on the modified Rankin Scale (mRS) at 180 days, analysed in the intention-to-treat population. This trial is registered with ClincalTrials.gov, NCT02258919, and is completed.
    Findings: SWITCH had to be stopped early due to lack of funding. Between Oct 6, 2014, and April 4, 2023, 201 individuals were randomly assigned and 197 gave delayed informed consent (96 decompressive craniectomy plus best medical treatment, 101 best medical treatment). 63 (32%) were women and 134 (68%) men, the median age was 61 years (IQR 51-68), and the median haematoma volume 57 mL (IQR 44-74). 42 (44%) of 95 participants assigned to decompressive craniectomy plus best medical treatment and 55 (58%) assigned to best medical treatment alone had an mRS of 5-6 at 180 days (adjusted risk ratio [aRR] 0·77, 95% CI 0·59 to 1·01, adjusted risk difference [aRD] -13%, 95% CI -26 to 0, p=0·057). In the per-protocol analysis, 36 (47%) of 77 participants in the decompressive craniectomy plus best medical treatment group and 44 (60%) of 73 in the best medical treatment alone group had an mRS of 5-6 (aRR 0·76, 95% CI 0·58 to 1·00, aRD -15%, 95% CI -28 to 0). Severe adverse events occurred in 42 (41%) of 103 participants receiving decompressive craniectomy plus best medical treatment and 41 (44%) of 94 receiving best medical treatment.
    Interpretation: SWITCH provides weak evidence that decompressive craniectomy plus best medical treatment might be superior to best medical treatment alone in people with severe deep intracerebral haemorrhage. The results do not apply to intracerebral haemorrhage in other locations, and survival is associated with severe disability in both groups.
    Funding: Swiss National Science Foundation, Swiss Heart Foundation, Inselspital Stiftung, and Boehringer Ingelheim.
    Language English
    Publishing date 2024-05-14
    Publishing country England
    Document type Journal Article
    ZDB-ID 3306-6
    ISSN 1474-547X ; 0023-7507 ; 0140-6736
    ISSN (online) 1474-547X
    ISSN 0023-7507 ; 0140-6736
    DOI 10.1016/S0140-6736(24)00702-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Obtaining regulatory approval for multicentre randomised controlled trials: experiences in the STICH II trial.

    Kenyon, Gillian M / Mendelow, Alexander David / Gregson, Barbara A / Rowan, Elise

    British journal of neurosurgery

    2011  Volume 25, Issue 3, Page(s) 352–356

    Abstract: Background and purpose: Centres wishing to participate in international multicentre randomised controlled surgical trials such as STICH II (Surgical Trial in Lobar Intracerebral Haemorrhage) have to go through a number of regulatory hurdles. These ... ...

    Abstract Background and purpose: Centres wishing to participate in international multicentre randomised controlled surgical trials such as STICH II (Surgical Trial in Lobar Intracerebral Haemorrhage) have to go through a number of regulatory hurdles. These depend on the nature of the study. In surgical studies, there is a need to obtain ethical approval and individual hospital approval including fully executing contracts between the host organisation and each institution. Firsthand experience has been gained in STICH II by guiding over 80 hospitals through this process in over 20 different countries worldwide.
    Methods: This article examines the administrative challenges of setting up the STICH II trial which include the time that it has taken for each hospital to obtain ethical approval, sign the study agreement and become a fully registered site. The aim of this article is to inform potential triallists planning multinational surgical trials about the potential delays and difficulties that may be encountered in the hope that it will encourage the medical research community to simplify administrative systems. We also hope to influence trial funders to build in 'start up periods' for new studies so that they can get up and running in a realistic time frame. The difficulties which were faced will be highlighted so that the organisers of other randomised controlled surgical trials can be aware of these delays.
    Conclusion: From the experiences in this trial, it can be concluded that delays will be experienced in obtaining ethical approval and in agreeing on site contracts.
    MeSH term(s) Cerebral Hemorrhage/surgery ; Ethics Committees/organization & administration ; Guidelines as Topic ; Humans ; Multicenter Studies as Topic/ethics ; Prospective Studies ; Randomized Controlled Trials as Topic/ethics
    Language English
    Publishing date 2011-02-28
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 639029-8
    ISSN 1360-046X ; 0268-8697
    ISSN (online) 1360-046X
    ISSN 0268-8697
    DOI 10.3109/02688697.2010.551675
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Development of anterior inferior cerebellar artery pseudoaneurysm after gamma knife surgery for vestibular schwannoma. A case report and review of the literature.

    Sunderland, Geraint / Hassan, Faizul / Bhatnagar, Priya / Mitchell, Patrick / Jayakrishnan, Vijayam / Forster, David / Mendelow, Alexander David

    British journal of neurosurgery

    2014  Volume 28, Issue 4, Page(s) 536–538

    Abstract: Gamma knife surgery (GKS) is a well-established modality for controlling the progression of vestibular schwannomas. Adverse effects of this treatment are extremely rare but include cyst formation and malignant transformation. We report a case of anterior ...

    Abstract Gamma knife surgery (GKS) is a well-established modality for controlling the progression of vestibular schwannomas. Adverse effects of this treatment are extremely rare but include cyst formation and malignant transformation. We report a case of anterior inferior cerebellar artery (AICA) pseudoaneurysm development rupture presenting as a poor WFNS grade subarachnoid haemorrhage. This is only the fourth case of aneurysm development (AICA aneurysm) following GKS reported but due to its serious nature we believe this potential complication warrants awareness in those offering this treatment.
    MeSH term(s) Aneurysm, False/diagnosis ; Aneurysm, False/etiology ; Aneurysm, False/surgery ; Basilar Artery/pathology ; Cerebral Arteries/pathology ; Female ; Humans ; Middle Aged ; Neuroma, Acoustic/diagnosis ; Neuroma, Acoustic/surgery ; Postoperative Complications/prevention & control ; Radiosurgery/adverse effects
    Language English
    Publishing date 2014-08
    Publishing country England
    Document type Case Reports ; Journal Article ; Review
    ZDB-ID 639029-8
    ISSN 1360-046X ; 0268-8697
    ISSN (online) 1360-046X
    ISSN 0268-8697
    DOI 10.3109/02688697.2013.847168
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top